Answers are grounded in this paper and cite their sources.
) delayed tumor progression. These findings suggest that epigenetic-based therapies may provide an alternative treatment option in hypermethylated T-ALL.
No takes yet. Share an insight, caveat, or question.
Touzart et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: